These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16920383)

  • 1. Expression of Ki-67 and p53 in cutaneous free flaps used to reconstruct soft tissue defects following resection of oral squamous cell carcinoma.
    Max Robinson C; Prime SS; Paterson IC; Guest PG; Eveson JW
    Oral Oncol; 2007 Mar; 43(3):263-71. PubMed ID: 16920383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias.
    Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
    Kerdpon D; Rich AM; Reade PC
    Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
    Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
    J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity.
    Angiero F; Berenzi A; Benetti A; Rossi E; Del Sordo R; Sidoni A; Stefani M; Dessy E
    Anticancer Res; 2008; 28(5A):2535-9. PubMed ID: 19035275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical expression of p53 protein in squamous epithelial carcinomas and normal and dysplastic epithelium of the mouth cavity].
    Piffkó J; Bánkfalvi A
    Mund Kiefer Gesichtschir; 1997 Mar; 1(2):104-7. PubMed ID: 9410611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
    Kushner J; Bradley G; Jordan RC
    J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.
    Iamaroon A; Khemaleelakul U; Pongsiriwet S; Pintong J
    J Oral Pathol Med; 2004 Jan; 33(1):30-6. PubMed ID: 14675138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of laminin-5 in oral dysplasia and squamous cell carcinoma.
    Rani V; McCullough M; Chandu A
    J Oral Maxillofac Surg; 2013 Nov; 71(11):1873-9. PubMed ID: 23891017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia.
    Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Martinez-Lara I
    Head Neck; 2000 Oct; 22(7):658-61. PubMed ID: 11002319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 protein in oral submucous fibrosis, oral epithelial hyperkeratosis, and oral epithelial dysplasia.
    Chiang CP; Lang MJ; Liu BY; Wang JT; Leu JS; Hahn LJ; Kuo MY
    J Formos Med Assoc; 2000 Mar; 99(3):229-34. PubMed ID: 10820956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium.
    Ichikawa M; Ishii K; Nakajima T; Mogi K
    J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of cell proliferation in oral epithelial dysplastic lesions.
    Oliver RJ; MacDonald DG; Felix DH
    J Oral Pathol Med; 2000 Feb; 29(2):49-55. PubMed ID: 10718399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analyses of Ki-67, cytokeratin 13 and cytokeratin 17 in diagnosis and prognosis of oral precancerous lesions.
    Yagyuu T; Obayashi C; Ueyama Y; Takano M; Tanaka Y; Kawaguchi M; Takeda M; Kasai T; Kirita T
    J Oral Pathol Med; 2015 Aug; 44(7):523-31. PubMed ID: 25243470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of p53, caspase-3, Bcl-2, and Ki-67 markers in oral squamous cell carcinoma and premalignant epithelium in a sample from Alava Province (Spain).
    Bascones-Martínez A; Rodríguez-Gutierrez C; Rodríguez-Gómez E; Gil-Montoya JA; Gómez-Font R; González-Moles MÁ
    Med Oral Patol Oral Cir Bucal; 2013 Nov; 18(6):e846-50. PubMed ID: 23722133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From epithelial dysplasia to squamous carcinoma of the head and neck region: evolutive and prognostic histopathological markers.
    Silvestri F; Bussani R; Pavletic N; Mannone T; Bosatra A
    Acta Otolaryngol Suppl; 1997; 527():49-51. PubMed ID: 9197481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.